Therapeutic targeting of IKK alpha in osteosarcoma using first-in-class selective IKK inhibitors

Plevin, Robin (Principal Investigator)
Cunningham, Margaret Rose (Co-investigator)

Project: Research

Status	Active
Effective start/end date	1/01/25 → 31/12/26

Funding

Bone Cancer Research Trust: £34,000.00

Bad to the bone: An RNA-sequencing study identifying a role for IKK alpha inosteosarcoma cell division and progression
Tinto, K., Bonfanti, M., Cunningham, M. R. & Plevin, R., Feb 2025, In: British Journal of Pharmacology. p. 702-703 2 p.
Research output: Contribution to journal › Conference abstract › peer-review